| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/09/2006 | WO2006003427A8 A protein involved in carcinoma |
| 03/09/2006 | WO2005118644A3 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 03/09/2006 | WO2005117931A3 Glut1 transporters expressed in cancer cells |
| 03/09/2006 | WO2005116640A3 Identification of anti-prion drugs by high-throughput screening based on sift |
| 03/09/2006 | WO2005111606A3 Use of a film having a hydrophilic surface in medical diagnostic strips |
| 03/09/2006 | WO2005103684A3 Diagnostics and therapeutics for diseases associated with cx3c chemokine receptor 1 (cx3cr1) |
| 03/09/2006 | WO2005100604A8 Methods for identifying risk of osteoarthritis and treatments thereof |
| 03/09/2006 | WO2005098444A3 Monocarboxylate transporters expressed in cancer cells |
| 03/09/2006 | WO2005095631A3 Diagnostics and therapeutics for diseases associated with mixed lineage kinase 4 alpha (mlk4 alpha) |
| 03/09/2006 | WO2005086891A3 Classification of breast cancer patients using a combination of clinical criteria and informative genesets |
| 03/09/2006 | WO2005083443A3 Prion immunoassay and separation method |
| 03/09/2006 | WO2005083105A3 Diagnostics and therapeutics for diseases associated with glycogen synthase kinase 3 beta (gsk3b) |
| 03/09/2006 | WO2005081930A3 Heath monitoring method and apparatus for composite materials |
| 03/09/2006 | WO2005073921A3 System and methods for screening a luminal organ |
| 03/09/2006 | WO2005055925A3 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types |
| 03/09/2006 | WO2005048165A3 Method to predict upper aerodigestive tract cancer |
| 03/09/2006 | WO2005040228A3 Disintegratable films for diagnostic devices |
| 03/09/2006 | WO2005038460A3 Site-specific labeling of affinity tags in fusion proteins |
| 03/09/2006 | WO2005012866A3 Soil compaction measurement on moving platform |
| 03/09/2006 | WO2004108901A3 A library of phylogenetically related sequences |
| 03/09/2006 | WO2004098391A3 Methods for detecting parvovirous infections |
| 03/09/2006 | US20060053499 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances |
| 03/09/2006 | US20060053498 Full-length human cdnas encoding potentially secreted proteins |
| 03/09/2006 | US20060053496 Caterpiller gene family |
| 03/09/2006 | US20060052953 Analyzing system for the detection of reducing and oxidizing gases in a carrier gas with a metal-oxide-semiconductor sensor arrangement |
| 03/09/2006 | US20060052950 Gas monitoring system and sidestream gas measurement system adapted to communicate with a mainstream gas measurement system |
| 03/09/2006 | US20060052947 Biofabrication of transistors including field effect transistors |
| 03/09/2006 | US20060052810 Tissue penetration device |
| 03/09/2006 | US20060052682 Biological testing system |
| 03/09/2006 | US20060052681 Body fluid collection and analysis |
| 03/09/2006 | US20060052593 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions |
| 03/09/2006 | US20060052591 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 03/09/2006 | US20060052584 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof |
| 03/09/2006 | US20060052582 Identification of inhibitors of mitosis |
| 03/09/2006 | US20060052329 Regulation of human P2Y1-like G protein-coupled receptor |
| 03/09/2006 | US20060052293 For therapy of obesity, hypertriglyceridemia, diet-induced insulin resistance, and/or type 2 diabetes |
| 03/09/2006 | US20060052285 Induction of mitochondrial membrane permeabilization via the physical and functional interaction of the HIV-1 Vpr protein with the mitochondrial inner membrane protein ANT (also called adenine nucleotide translocase or ADP/ATP carrier) |
| 03/09/2006 | US20060052282 Diagnostic and therapeutic means for pathologies associated with alpha 2 subunit of the na, k pump |
| 03/09/2006 | US20060052279 For electrophoretic or chromatographic analysis; uniform coupling without overstaining; proteins in a biological sample that is sought to be analyzed by an electrophoretic or chromatographic procedure are coupled to a dye in efficient manner by combining sample with solid dye, buffer, denaturing agent |
| 03/09/2006 | US20060052278 Diagnosis and treatment of human dormancy-related sequellae |
| 03/09/2006 | US20060051976 Nanoporous membrane reactor for miniaturized reactions and enhanced reaction kinetics |
| 03/09/2006 | US20060051879 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 03/09/2006 | US20060051878 Nano-sized optical fluorescence labels and uses thereof |
| 03/09/2006 | US20060051877 Fibronectin biopolymer marker indicative of insulin resistance |
| 03/09/2006 | US20060051876 System and apparatus for sequential processing of analytes |
| 03/09/2006 | US20060051875 Method for detecting a plurality of different species |
| 03/09/2006 | US20060051873 Assessment of cardiovascular risk |
| 03/09/2006 | US20060051872 Synthesis and use of inorganic polymer sensor for detecting nitroaromatic compounds |
| 03/09/2006 | US20060051871 Method for determining the amount of the maleimidyl groups of a particle |
| 03/09/2006 | US20060051836 Molecules for disease detection and treatment |
| 03/09/2006 | US20060051835 Pael receptor, cells and animal expressing pael receptor and method of screning remedy for parkinson's disease |
| 03/09/2006 | US20060051833 composition consisting of a population of cells having retained therein a detectable product resulting from conversion by the cell of BODIPY aminoacetaldehyde to the detectable product BODIPY aminoacetate |
| 03/09/2006 | US20060051832 Modified sarcosine oxidase, process for producing the same and reagent composition using the same |
| 03/09/2006 | US20060051828 Diagnostic test for determining the concentration of transient proteolytic activity in composite biological media |
| 03/09/2006 | US20060051827 Using enhanced luciferase as reporter molecule to monitor molecular events in biology, biochemistry, immunology and cell biology |
| 03/09/2006 | US20060051825 Methods and compositions for measuring canine BNP and uses thereof |
| 03/09/2006 | US20060051824 Tetrahydrocannabinoid antigens and method of use |
| 03/09/2006 | US20060051823 specific antigenic proteins and peptides unique to Treponema pallidum; diagnosis of syphilis; immunoassay of acidic repeat protein/immunogens |
| 03/09/2006 | US20060051822 Methods for detecting Bacillus thuringiensis cryET33 and cry ET34 polypeptides |
| 03/09/2006 | US20060051821 Methods and kits for use in the diagnosis and treatment of endotoxemia |
| 03/09/2006 | US20060051820 Method of examing staphylococcus aureus |
| 03/09/2006 | US20060051819 Detection, evaluation and treatment for advanced prostate cancer |
| 03/09/2006 | US20060051818 Method for ngf assay for in vitro diagnosis of breast cancer and therapeutic use |
| 03/09/2006 | US20060051817 Uses of Gangliosides GM1 and/or asialo-GM1 substances simulating the carbohydrate portion of the gangliosides; early diagnosis of cancer; carcinoma |
| 03/09/2006 | US20060051816 Rare cell detection using flat-panel imager and chemiluminescent or radioisotopic tags |
| 03/09/2006 | US20060051815 Methods of treating smooth muscle cell disorders |
| 03/09/2006 | US20060051814 Methods for predicting outcome in traumatic brain injury |
| 03/09/2006 | US20060051813 Diagnostic method for a transmissible spongiform encephalopathy or prion disease |
| 03/09/2006 | US20060051811 Site-specific labelling of proteins using acridone and quinacridone lifetime dyes |
| 03/09/2006 | US20060051809 Detection of nucleic acids by target-specific hybrid capture method |
| 03/09/2006 | US20060051805 Method for detecting binding of nucleic acid and nucleic acid binding protein by monomolecular fluorescent analysis |
| 03/09/2006 | US20060051792 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051786 Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder |
| 03/09/2006 | US20060051785 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051784 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051783 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051780 Polymorphic Plasminogen genes and uses thereof |
| 03/09/2006 | US20060051778 Diagnosis of systemic lupus erythematosus |
| 03/09/2006 | US20060051777 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/09/2006 | US20060051775 Non-invasive method for isolation and detection of fetal DNA |
| 03/09/2006 | US20060051774 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of prostate cancer |
| 03/09/2006 | US20060051767 By modulating acetylation of cytochrome c, cytochrome c induced cellular processes such as apoptosis and mitochondrial function (e.g., respiration) can be modulated; modulation of cytochrome c acetylation with SIR polypeptide enables interventions that modulate lifespan regulation and cell proliferation |
| 03/09/2006 | US20060051763 Detection methods |
| 03/09/2006 | US20060051762 Fixation carrier and solid phase |
| 03/09/2006 | US20060051760 Compositions and methods used for identifying factors required for the agglomeration of proteins |
| 03/09/2006 | US20060051758 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups |
| 03/09/2006 | US20060051757 Diagnostic and therapeutic use of ensadin-0477 gene and protein for neurodegenerative diseases |
| 03/09/2006 | US20060051755 Methods of assaying for cell cycle modulators |
| 03/09/2006 | US20060051753 Methods for determining the response of cells to vegf and uses thereof |
| 03/09/2006 | US20060051750 Method for fixing biomolecule on carrier |
| 03/09/2006 | US20060051742 Novel assay for the separation and quantification of hemagglutinin antigens |
| 03/09/2006 | US20060051741 Plate for mass spectrometry, process for preparing the same and use thereof |
| 03/09/2006 | US20060051740 Method for the amplification and detection of hbv dna using a transcription based amplification |
| 03/09/2006 | US20060051739 Methods and composition for visualizing and interfering with chromosomal tethering of extrachromosomal molecules |
| 03/09/2006 | US20060051738 Dual glucose-turbidimetric analytical sensors |
| 03/09/2006 | US20060051733 Monitoring of cells |
| 03/09/2006 | US20060051367 Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences |
| 03/09/2006 | US20060051362 Antigens for actinobacillus pleuropneumoniae and methods thereof |
| 03/09/2006 | US20060051358 Immune response assessment method |
| 03/09/2006 | US20060051350 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (GITR or TNFRSF18) |